Wellington Management Group
IART icon

Wellington Management Group’s Integra LifeSciences IART Stock Holding History

Wellington Management Group’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.2M Sell
1,300,290
-53,177
-4% -$584K ﹤0.01% 1191
2025
Q4 		$16.8M Buy
1,353,467
+32,192
+2% +$428K ﹤0.01% 1103
2025
Q3 		$18.9M Sell
1,321,275
-2,493
-0.2% -$34.2K ﹤0.01% 1046
2025
Q2 		$16.2M Sell
1,323,768
-1,442,357
-52% -$20.9M ﹤0.01% 1045
2025
Q1 		$60.8M Buy
2,766,125
+259,987
+10% +$6.11M 0.01% 633
2024
Q4 		$56.8M Buy
2,506,138
+303,779
+14% +$6.63M 0.01% 675
2024
Q3 		$40M Sell
2,202,359
-1,684,161
-43% -$39M 0.01% 759
2024
Q2 		$113M Buy
3,886,520
+548,096
+16% +$16.3M 0.02% 509
2024
Q1 		$118M Buy
3,338,424
+153,131
+5% +$6.12M 0.02% 512
2023
Q4 		$139M Buy
3,185,293
+151,344
+5% +$5.96M 0.03% 484
2023
Q3 		$116M Sell
3,033,949
-323,813
-10% -$13.6M 0.02% 484
2023
Q2 		$138M Sell
3,357,762
-1,407,478
-30% -$67.7M 0.03% 470
2023
Q1 		$274M Sell
4,765,240
-808,786
-15% -$45.6M 0.05% 318
2022
Q4 		$313M Buy
5,574,026
+364,403
+7% +$18.5M 0.06% 289
2022
Q3 		$221M Sell
5,209,623
-1,474,940
-22% -$75.6M 0.05% 357
2022
Q2 		$361M Sell
6,684,563
-718,511
-10% -$43.2M 0.07% 239
2022
Q1 		$476M Sell
7,403,074
-2,317,302
-24% -$153M 0.08% 222
2021
Q4 		$651M Buy
9,720,376
+109,034
+1% +$7.38M 0.1% 197
2021
Q3 		$658M Buy
9,611,342
+364,300
+4% +$25.7M 0.11% 185
2021
Q2 		$631M Buy
9,247,042
+52,919
+0.6% +$3.74M 0.11% 203
2021
Q1 		$635M Sell
9,194,123
-69,271
-0.7% -$4.69M 0.11% 193
2020
Q4 		$601M Buy
9,263,394
+1,442,250
+18% +$77.6M 0.11% 189
2020
Q3 		$369M Buy
7,821,144
+2,387,385
+44% +$114M 0.08% 232
2020
Q2 		$255M Buy
5,433,759
+232,819
+4% +$11.4M 0.06% 289
2020
Q1 		$232M Buy
5,200,940
+34,180
+0.7% +$1.79M 0.06% 265
2019
Q4 		$301M Buy
5,166,760
+121,452
+2% +$7.23M 0.06% 297
2019
Q3 		$303M Buy
5,045,308
+370,471
+8% +$22.1M 0.07% 273
2019
Q2 		$261M Buy
4,674,837
+217,092
+5% +$11.2M 0.06% 302
2019
Q1 		$248M Buy
4,457,745
+149,640
+3% +$7.62M 0.06% 315
2018
Q4 		$194M Buy
4,308,105
+443,756
+11% +$24.3M 0.05% 342
2018
Q3 		$255M Buy
3,864,349
+1,407,050
+57% +$87.4M 0.05% 330
2018
Q2 		$158M Buy
2,457,299
+328,535
+15% +$20.3M 0.04% 445
2018
Q1 		$118M Buy
2,128,764
+208,047
+11% +$10.9M 0.03% 527
2017
Q4 		$91.9M Buy
1,920,717
+624,451
+48% +$30.6M 0.02% 589
2017
Q3 		$65.4M Buy
1,296,266
+678,798
+110% +$34.9M 0.02% 674
2017
Q2 		$33.7M Buy
617,468
+93,547
+18% +$4.47M 0.01% 852
2017
Q1 		$22.1M Sell
523,921
-2,933
-0.6% -$125K 0.01% 995
2016
Q4 		$22.6M Buy
+526,854
New +$21.4M 0.01% 965
2015
Q3 		– Sell
-303,622
Closed -$8.36M – 2208
2015
Q2 		$8.36M Buy
303,622
+14,606
+5% +$389K ﹤0.01% 1268
2015
Q1 		$7.28M Buy
289,016
+23,755
+9% +$562K ﹤0.01% 1340
2014
Q4 		$5.88M Sell
265,261
-739,860
-74% -$15M ﹤0.01% 1398
2014
Q3 		$20.4M Buy
1,005,121
+743,153
+284% +$14.8M 0.01% 1005
2014
Q2 		$5.04M Buy
261,968
+15,975
+6% +$298K ﹤0.01% 1451
2014
Q1 		$4.62M Sell
245,993
-6,728
-3% -$130K ﹤0.01% 1488
2013
Q4 		$4.93M Sell
252,721
-2,691
-1% -$49.4K ﹤0.01% 1463
2013
Q3 		$4.2M Sell
255,412
-11,498
-4% -$184K ﹤0.01% 1481
2013
Q2 		$4M Buy
+266,910
New +$3.91M ﹤0.01% 1481

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group's IART Position: Q1 2026 in Review

Wellington Management Group reduced its Integra LifeSciences (IART) stake by 3.9% in Q1 2026, selling an estimated $584K and leaving 1,300,290 shares worth $12.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1191.

Wellington Management Group first reported a position in IART in Q2 2013 and has held it in 47 quarters since. The position peaked at $658M in Q3 2021. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • Wellington Management Group held 1,300,290 shares of Integra LifeSciences worth $12.2M as of Q1 2026.
  • Wellington Management Group sold 53,177 Integra LifeSciences shares in Q1 2026, an estimated $584K.
  • Integra LifeSciences made up ﹤0.01% of Wellington Management Group's portfolio in Q1 2026, its #1191 holding.
  • Wellington Management Group first reported a position in Integra LifeSciences in Q2 2013 and has held it in 47 quarters since.
  • Wellington Management Group's Integra LifeSciences position peaked at $658M in Q3 2021.
  • 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.